glp-1 and neuroinflammation Beyond diabetes obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and - Spezani - 2026 - Diabetes, Obesity and Metabolism Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
Agonista del receptor GLP-1 que estimula la secrecin de insulina dependiente de glucosa, suprime el glucagn e inhibe el vaciamiento gstrico
R.BourdetD
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
10.1007/s11154-022-09735-8 7 BakM
GLP-2 analogs positively influence nutrient absorption in animal models and humans, although continued therapy is likely needed for sustained effects
this was the final number of subjects included in the analysis
